MedMates Company Member

Alcinous Pharmaceuticals

Novel Interactions with Therapeutic Targets

 

We strive to design and develop therapeutics for aggressive cancers. Founded in 2016 by three PhD students at the University of Rhode Island, Alcinous Pharmaceuticals uses a novel drug discovery pipeline in tandem with their innovative team to develop new classes of therapeutics. Alcinous was founded on the belief that through sophisticated computer modeling we could design and develop new therapies that were , safe, effective, and affordable for our patients.

 

Research Activities

  • small molecule
  • drug design
  • drug development

 

Products or Services

  • small molecule
  • orphan drugs
  • medicinal chemistry
  • computer aided drug design

 

Markets Served

  • oncology